Drugs / CMV Specific Cytotoxic T Lymphocytes
last change Aug 2008 re-read 3 minutes ago

CMV Specific Cytotoxic T Lymphocytes

Cell therapy

Developed for
cytomegalovirus infection
Investigated by
Milton S. Hershey Medical Center

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00673868 Oct 2007 → Aug 2008 cytomegalovirus infection Milton S. Hershey Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CMV Specific Cytotoxic T Lymphocytes ClinicalTrials.gov intervention name — accepted as the source's own label NCT00673868 ↗
Modality Cell therapy “T-cell infusion” NCT00673868 ↗